標(biāo)題: Titlebook: Clinical Use of Antibodies; Tumours, infection, Richard P. Baum,Peter H. Cox,Gian Luigi Buraggi Book 1991 Springer Science+Business Media [打印本頁(yè)] 作者: hierarchy 時(shí)間: 2025-3-21 17:11
書(shū)目名稱(chēng)Clinical Use of Antibodies影響因子(影響力)
書(shū)目名稱(chēng)Clinical Use of Antibodies影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Clinical Use of Antibodies網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Clinical Use of Antibodies網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Clinical Use of Antibodies被引頻次
書(shū)目名稱(chēng)Clinical Use of Antibodies被引頻次學(xué)科排名
書(shū)目名稱(chēng)Clinical Use of Antibodies年度引用
書(shū)目名稱(chēng)Clinical Use of Antibodies年度引用學(xué)科排名
書(shū)目名稱(chēng)Clinical Use of Antibodies讀者反饋
書(shū)目名稱(chēng)Clinical Use of Antibodies讀者反饋學(xué)科排名
作者: covert 時(shí)間: 2025-3-21 22:48
New Developments in the Diagnosis of Aids and Strategies for Therapy,in the medical community as well as in public, and it was probably the mostly discussed disease over the last decade. I therefore assume that the clinical symptoms and the time course are widely known.作者: 婚姻生活 時(shí)間: 2025-3-22 03:25
Biological Rhythms and the Day-Night Cycle,, as well as our understanding of some aspects of the malignant process (1–3). A very large number of rodent MAbs have been developed for the use in the diagnosis, detection, monitoring, and treatment of various neoplasms, many of which have been generated against tumor-associated antigens, growth f作者: 原告 時(shí)間: 2025-3-22 07:26 作者: Prostatism 時(shí)間: 2025-3-22 12:34 作者: AER 時(shí)間: 2025-3-22 14:00
Sb Organoantimony Compounds Part 4 seem adequate to allow a new technique to acquire full maturity and take its place in routine use among the other conventionalimaging methods, (ultrasonographypomputed tomographyand magneticresonance imaging). However, immunoscintigraphy has not reached this stage of routine clinical use, particula作者: AER 時(shí)間: 2025-3-22 18:20 作者: 松緊帶 時(shí)間: 2025-3-22 23:17
https://doi.org/10.1007/978-3-662-06312-5rapy concept based on bispecific MAbs which might be more effective. To work out this concept we first showed that penetration into human carcinoma xenografts as well as long term storage of intact MAb outside the carcinoma cells are possible. Epitope saturation was however not yet obtained despite 作者: hypnogram 時(shí)間: 2025-3-23 05:23
https://doi.org/10.1007/978-3-031-22528-4es. Planar or single photon emission computed tomography (SPECT) techniques using Indium- 111 labelled antibody have been used for the clinical detection of myocardial necrosis, both in acute myocardial infarction, and in myocarditis. This article reviews the role of antimyosin (AM) imaging in myoca作者: 表狀態(tài) 時(shí)間: 2025-3-23 09:18 作者: 迅速成長(zhǎng) 時(shí)間: 2025-3-23 10:14
Sc, Y, La-Lu Rare Earth Elementsrol (CDC) (23). Subsequently there have been numerous invasive and non — invasive methods proposed for the early diagnosis and treatment of this usually fatal disorder. This article reviews the ongoing role of Nuclear Medicine in the diagnosis of HIV infection and HIV related diseases over the last 作者: 陳列 時(shí)間: 2025-3-23 16:41 作者: 滔滔不絕地講 時(shí)間: 2025-3-23 20:29
https://doi.org/10.1007/978-3-031-26070-4in the medical community as well as in public, and it was probably the mostly discussed disease over the last decade. I therefore assume that the clinical symptoms and the time course are widely known.作者: CODE 時(shí)間: 2025-3-23 22:35 作者: 調(diào)整 時(shí)間: 2025-3-24 05:44
978-94-010-5555-0Springer Science+Business Media Dordrecht 1991作者: 冷淡周邊 時(shí)間: 2025-3-24 08:42 作者: Fulsome 時(shí)間: 2025-3-24 11:48 作者: 先兆 時(shí)間: 2025-3-24 17:07
Rare Earth Elements and Tellurium,Ovarian Cancer is a debilitating disease. It usually presents in an advanced state and then requires radical surgery and repeated courses of chemotherapy.lt is the second most common cause of death due to cancer in women.作者: 現(xiàn)實(shí) 時(shí)間: 2025-3-24 23:02 作者: entrance 時(shí)間: 2025-3-24 23:12
Recent Advances in the Use of Radiolabelled Monoclonal Antibodies in the Management of Ovarian CancOvarian Cancer is a debilitating disease. It usually presents in an advanced state and then requires radical surgery and repeated courses of chemotherapy.lt is the second most common cause of death due to cancer in women.作者: HATCH 時(shí)間: 2025-3-25 05:03 作者: fiscal 時(shí)間: 2025-3-25 09:58
Developments in Nuclear Medicinehttp://image.papertrans.cn/c/image/228282.jpg作者: 門(mén)閂 時(shí)間: 2025-3-25 13:58 作者: Jocose 時(shí)間: 2025-3-25 18:42
Book 1991logical innovations in the field of immunology -the production of monoclonal antibodies. It happens that, the time of the publication of this book, just a decade has passed since the first use of radiolabelled monoclonal antibodies in man (by the Lausanne Group). Over these 10 years a tremendous pro作者: 內(nèi)疚 時(shí)間: 2025-3-25 22:30
ary technological innovations in the field of immunology -the production of monoclonal antibodies. It happens that, the time of the publication of this book, just a decade has passed since the first use of radiolabelled monoclonal antibodies in man (by the Lausanne Group). Over these 10 years a tremendous pro978-94-010-5555-0978-94-011-3516-0作者: FADE 時(shí)間: 2025-3-26 00:15
Biological Rhythms and the Day-Night Cycle,fy markers of cell types and certain pathological changes in tissue specimens, and to detect sites of cancer by external imaging methods (2). Therapeuticallythey have been used either as unconjugated (“naked”) antibodies or to target drugs, toxins, effectorlymphocytes, cytokines, and radionuclidesto tumors (3–5).作者: 損壞 時(shí)間: 2025-3-26 06:19
https://doi.org/10.1007/978-3-662-06312-5ntigraphy using 123-I labelled F(ab’)2 fragments of anti-CEA monoclonal antibodies may be a useful tool in monitoring patients with gastrointestinal tumours in terms of confirming the results of conventional methods or revealing disease sites undetected by conventional radiology.作者: Pedagogy 時(shí)間: 2025-3-26 09:44 作者: Inelasticity 時(shí)間: 2025-3-26 13:07
Advances in Cancer Imaging and Therapy with Radiolabelled Antibodies,fy markers of cell types and certain pathological changes in tissue specimens, and to detect sites of cancer by external imaging methods (2). Therapeuticallythey have been used either as unconjugated (“naked”) antibodies or to target drugs, toxins, effectorlymphocytes, cytokines, and radionuclidesto tumors (3–5).作者: jumble 時(shí)間: 2025-3-26 19:02
,Use of 123-I Radiolabelled F(AB’)2 Fragments of Anti-CEA Monoclonal Antibody for the Detection of Pntigraphy using 123-I labelled F(ab’)2 fragments of anti-CEA monoclonal antibodies may be a useful tool in monitoring patients with gastrointestinal tumours in terms of confirming the results of conventional methods or revealing disease sites undetected by conventional radiology.作者: 極力證明 時(shí)間: 2025-3-27 00:41 作者: Eosinophils 時(shí)間: 2025-3-27 01:26 作者: certitude 時(shí)間: 2025-3-27 05:17 作者: chiropractor 時(shí)間: 2025-3-27 10:50
https://doi.org/10.1007/978-3-031-22528-4ion of myocardial necrosis, both in acute myocardial infarction, and in myocarditis. This article reviews the role of antimyosin (AM) imaging in myocardial infarction diagnosis and risk stratification.作者: 貨物 時(shí)間: 2025-3-27 14:47
Sc, Y, La-Lu Rare Earth Elementsly fatal disorder. This article reviews the ongoing role of Nuclear Medicine in the diagnosis of HIV infection and HIV related diseases over the last decade as well as some recently introduced radionuclide investigations that are still in the realm of “work in progress”.作者: 障礙物 時(shí)間: 2025-3-27 20:27
Evaluation of the Diagnostic Utility of Immunoscintigraphy in Oncology, of a large number of patients are very good and it seems important, for the development of these methods to widen the field of clinical applications both with new prospective trials and with extensive use of RIS in daily routine.作者: FUSC 時(shí)間: 2025-3-28 01:46
Antimyosin Antibody Imaging in Myocardial Infarction,ion of myocardial necrosis, both in acute myocardial infarction, and in myocarditis. This article reviews the role of antimyosin (AM) imaging in myocardial infarction diagnosis and risk stratification.作者: 統(tǒng)治人類(lèi) 時(shí)間: 2025-3-28 03:48 作者: 摻和 時(shí)間: 2025-3-28 08:51 作者: Harpoon 時(shí)間: 2025-3-28 14:05
Book 1991 antibody-antigen interactio- on the occasion of the opening of the Institute for Experimental Therapeutics (which was later named after him). Nearly 100 years have passed since, and in retrospect it can be said that the "Ehrlich Era" (first steps in immunology "Magic Bullet" concept) and the "Behri作者: 遺忘 時(shí)間: 2025-3-28 18:40
https://doi.org/10.1007/978-3-662-06345-3ial thrombi and pulmonary embolism. The use of this antibody for the detection and characterisation of arterial thrombi in patients being considered for thrombolytic therapy would appear to be particularly promising. These studies demonstrate the clinical impact that these agents are potentially capable of producing.作者: spinal-stenosis 時(shí)間: 2025-3-28 21:57
https://doi.org/10.1007/978-3-662-07503-6ural epitope (CA 170) found on human tumours and which is recognised MAb 170 is still under extensive investigation. The present study details the potential of this antibody as an imaging agent for a broad spectrum of adenocarcinomas.作者: 增長(zhǎng) 時(shí)間: 2025-3-29 01:27
Monoclonal Antibodies for Cell Labelling with Particular Reference to Thrombus Imaging,ial thrombi and pulmonary embolism. The use of this antibody for the detection and characterisation of arterial thrombi in patients being considered for thrombolytic therapy would appear to be particularly promising. These studies demonstrate the clinical impact that these agents are potentially capable of producing.作者: Crater 時(shí)間: 2025-3-29 04:42 作者: Monotonous 時(shí)間: 2025-3-29 08:10
Clinical Utility of Radiolabelled Monoclonal Antibodies in the Management of Gastrointestinal Cancerly in the diagnostic evaluation of colorectal cancers. It would thus seem useful to analyze the reasons for this delay and to consider the real clinical utility of this new approach and its future prospects at short and middle term.作者: 諷刺 時(shí)間: 2025-3-29 14:14
Advances in Cancer Imaging and Therapy with Radiolabelled Antibodies,, as well as our understanding of some aspects of the malignant process (1–3). A very large number of rodent MAbs have been developed for the use in the diagnosis, detection, monitoring, and treatment of various neoplasms, many of which have been generated against tumor-associated antigens, growth f作者: Physiatrist 時(shí)間: 2025-3-29 16:04 作者: V洗浴 時(shí)間: 2025-3-29 22:30 作者: 大氣層 時(shí)間: 2025-3-30 03:22 作者: 外向者 時(shí)間: 2025-3-30 07:16
,Use of 123-I Radiolabelled F(AB’)2 Fragments of Anti-CEA Monoclonal Antibody for the Detection of Ptinal carcinomas. The antibody scans detected primary or metastatic disease in 4 out of 7 patients with known disease and they suggested the existence of disease in 3 cases, in sites not detected by conventional techniques. In 1 patient, liver metastases were detected with the antibody scan 3 months作者: Fermentation 時(shí)間: 2025-3-30 11:28
Bispecific Monoclonal Antibodies for two Phase Radioimmunotherapy,rapy concept based on bispecific MAbs which might be more effective. To work out this concept we first showed that penetration into human carcinoma xenografts as well as long term storage of intact MAb outside the carcinoma cells are possible. Epitope saturation was however not yet obtained despite 作者: Indict 時(shí)間: 2025-3-30 14:12 作者: 名次后綴 時(shí)間: 2025-3-30 19:02
Monoclonal Antibodies for Cell Labelling with Particular Reference to Thrombus Imaging,es against granulocytes being used for the detection of inflammation and localised infection and antibodies specific for platelets and fibrin being used for imaging thrombi. The use of monoclonal antibodies for cell labelling represents one of the most exciting of the recent developments in nuclear 作者: 突襲 時(shí)間: 2025-3-30 22:41 作者: Parley 時(shí)間: 2025-3-31 03:03
A New Marker for the Detection of Adenocarcinomas by Radioimmunoscintigraphy,ionize the fields of immunoscintigraphy. The application of such technology in the field od oncology has recently been reviewed (2,3). Our interest in carbohydrate expression as tumour markers for adenocarcimonas(4–9) and squamous cell carcimonas was extended towards the development of a generation
